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Vessel and blood specification override cardiac potential in
anterior mesoderm
Jeffrey J. Schoenebeck, Brian R. Keegan, and Deborah Yelon*
Developmental Genetics Program and Department of Cell Biology, Skirball Institute of Biomolecular
Medicine, New York University School of Medicine, New York, NY 10016 USA
SUMMARY
Organ progenitors arise within organ fields, embryonic territories that are larger than the regions
required for organ formation. Little is known about the regulatory pathways that define organ field
boundaries and thereby limit organ size. Here, we identify a mechanism for restricting heart size
through confinement of the developmental potential of the heart field. Via fate mapping in zebrafish,
we locate cardiac progenitors within hand2-expressing mesoderm and demonstrate that hand2
potentiates cardiac differentiation within this region. Beyond the rostral boundary of hand2
expression, we find progenitors of vessel and blood lineages. In embryos deficient in vessel and blood
specification, rostral mesoderm undergoes a fate transformation and generates ectopic
cardiomyocytes. Therefore, induction of vessel and blood specification represses cardiac
specification and delimits the capacity of the heart field. This regulatory relationship between
cardiovascular pathways suggests new strategies for directing progenitor cell differentiation to
facilitate cardiac regeneration.
INTRODUCTION
Organogenesis relies upon the production of a proper number of progenitor cells. A shortage
of progenitors can limit organ size and functional capacity, whereas a surplus of progenitors
can lead to organ enlargement and dysfunction. Organ progenitors are thought to arise within
“organ fields,” embryonic territories that possess the appropriate developmental potential but
are typically larger than the regions fated to contribute to the organ (Huxley and De Beer,
1934; Jacobson and Sater, 1988). Therefore, progenitor quantity is likely to be controlled by
the establishment of field boundaries and the gradual refinement of field potential. However,
the regulation of these processes is not well understood.
Enthusiasm for the possibilities of regenerative medicine has fueled interest in the mechanisms
that create and differentiate organ progenitors. For instance, identification of a source for
cardiac progenitors could facilitate cellular therapy aimed at regeneration of cardiac muscle
(Laflamme and Murry, 2005; van Laake et al., 2006). The origins of cardiac progenitors have
therefore attracted particular attention. Fate mapping studies have shown that cardiac
progenitors reside within bilateral heart-forming regions (HFRs) of the anterior lateral plate
mesoderm (ALPM) (Harvey, 2002; Yutzey and Kirby, 2002). The HFRs are the primary source
of the cardiomyocytes that compose the initial heart tube. In Xenopus and zebrafish, the HFRs
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are the only reported mesodermal source of cardiomyocytes (Raffin et al., 2000; Serbedzija et
al., 1998). In contrast, chick and mouse embryos contain a second source of cardiomyocytes
in a separate mesodermal territory. This region, called the second, or anterior, heart field,
contributes myocardium to the arterial and venous poles of the heart, including contributions
to the outflow tract, right ventricle, and atria (Buckingham et al., 2005; Kelly et al., 2001;
Mjaatvedt et al., 2001; Waldo et al., 2001; Cai et al., 2003; Zaffran et al., 2004). To date, the
embryonic and evolutionary origins of the second heart field remain unclear.
In frog and fish, the ALPM surrounding the HFRs appears to exhibit the breadth of
developmental potential expected of an organ field. In Xenopus, extirpated tissue from a lateral
portion of the ALPM can produce cardiomyocytes in vitro, even though this particular region
does not normally produce cardiomyocytes in vivo (Sater and Jacobson, 1990; Raffin et al.,
2000; Garriock and Drysdale, 2003). In zebrafish, removal of the anterior notochord allows
cardiac specification in ALPM just caudal to the HFRs (Goldstein and Fishman, 1998).
Furthermore, the zebrafish HFRs can rapidly be replenished after partial ablation, due to
contributions from rostral ALPM flanking these regions (Serbedzija et al., 1998). Together,
these studies indicate that the cardiogenic potential of the ALPM extends beyond the
boundaries of the genuine HFRs.
It is unclear how certain portions of the ALPM are kept from fulfilling their cardiac potential.
A few pathways have been implicated in the repression of cardiac fate assignment. For example,
Notch signaling seems to inhibit cardiac specification in lateral portions of the Xenopus ALPM
(Rones et al., 2000). Canonical Wnt signaling has also been suggested to repress cardiac
potential in chick, Xenopus, and mouse (Marvin et al., 2001; Schneider and Mercola, 2001;
Lickert et al., 2002). Finally, retinoic acid signaling appears to restrict the specification of
cardiac progenitors during gastrulation stages in zebrafish and Xenopus (Keegan et al., 2005;
Collop et al., 2006) and to inhibit cardiomyocyte differentiation within the ALPM in
Xenopus and chick (Osmond et al., 1991; Yutzey et al., 1994; Drysdale et al., 1997). It is not
known whether or how these pathways work together to refine the cardiogenic potential of the
heart field, and it is likely that important repressive influences remain to be revealed.
Here, we identify a potent mechanism for restricting cardiac specification within the heart field.
By constructing a fate map of the zebrafish ALPM, we establish that the boundaries of the
zebrafish HFR correspond to the boundaries of hand2 expression. Mesoderm beyond the rostral
limit of hand2 expression normally gives rise to vessel and blood lineages. However, this rostral
territory also harbors latent cardiac developmental potential. Embryos with defects in vessel
and blood specification exhibit too many cardiomyocytes, and these extra cells are the
consequence of a fate transformation that generates ectopic cardiac progenitors in rostral
mesoderm. These data demonstrate an important regulatory relationship between the
developmental programs that create the cardiovascular system: components of the vessel and
blood specification pathways repress cardiac specification and thereby limit heart size. This
interplay between pathways has implications for the mechanisms underlying cardiac evolution
and suggests new strategies for regenerative medicine.
RESULTS
Gene expression patterns divide the ALPM into three territories
In order to investigate the mechanisms that delimit cardiac potential in zebrafish, we first sought
to define the dimensions of the HFR relative to gene expression patterns in the zebrafish ALPM.
We chose to examine the expression of a group of transcription factor genes at the 6–9 somite
stage (Fig. 1), 3–4 hours prior to the onset of myocardial differentiation (Yelon et al., 1999).
At these stages, the ALPM appears as bilateral strips of tissue running along the lateral edges
of the embryonic anterior-posterior axis. A few genes (e.g. gata4, gata5, and tbx20) are
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expressed throughout the ALPM (Fig. 1B,E,H, and data not shown). In contrast, expression of
hand2 is confined to a relatively posterior portion of the ALPM, flanking the hindbrain and
extending below the tip of the notochord (Fig. 1A–C). Expression of hand2 in this portion of
the ALPM spans its width (Fig. 1A–C). This region is subdivided by nkx2.5 expression, which
is prominently expressed medially, but not detectable laterally (Fig. 1D–F,K). We find
expression of genes associated with vasculogenesis and hematopoiesis (e.g. scl, fli1a, spi1, and
lmo2) anterior to hand2, in the most rostral portion of the ALPM (Fig. 1G-J and data not shown).
Expression of rostral ALPM genes has no detectable overlap with hand2 expression (Fig. 1J).
Thus, gene expression patterns divide the ALPM into three distinct territories, hereafter
referred to as medial, lateral, and rostral ALPM (Fig. 1L).
Constructing a fate map of ALPM territories
Next, we investigated where cardiac progenitors reside within the three ALPM territories.
Medial ALPM has previously been shown to contain cardiac progenitors (Serbedzija et al.,
1998), but the cardiac contributions of lateral and rostral ALPM have not been explored. To
construct a fate map of the ALPM, we employed a photoactivatable DMNB-caged fluorescein
dextran conjugate as a lineage tracer. By adapting a photoactivation protocol previously used
for fate mapping at late blastula stages (Keegan et al., 2004), we labeled cells within the ALPM
at the 6–9 somite stage (Fig. 2A–C) and later assessed their fate (Fig. 2J–L). In each
experimental embryo, we labeled a cluster of 10–15 cells within a particular region: we
examined 2 regions within the rostral ALPM (Fig. 2D), 4 regions within the medial ALPM
(Fig. 2G), and 4 regions within the lateral ALPM (Fig. 2G). Use of visible anatomical
landmarks, such as the lateral edge of the ALPM, notochord, and brain structures, facilitated
accurate targeting of each region (Fig. 2D–I). Following heart formation, embryos were fixed
and processed to score contributions of labeled cells to the myocardium (Fig. 2J) and
endocardium (Fig. 2L). We also noted contributions to other mesodermal tissues, including
head vessels, head mesenchyme, and myeloid cells. Additionally, many experimental embryos
exhibited labeled progeny within the pharyngeal pouches (Fig. 2K); pharyngeal pouch labeling
is likely to reflect overlap of the migrating anterior endoderm and the ALPM at the 6-9 somite
stage (T. Wendl, D. Adzic, J.J.S., S. Scholpp, M. Brand, D.Y., and K. Rohr, manuscript
submitted).
The zebrafish HFR extends across medial and lateral territories
Our fate map data demonstrate the presence of myocardial progenitors within both medial and
lateral ALPM territories (Fig. 3). 72% of experiments in medial ALPM generated labeled
myocardial progeny (Fig. 3B, Table 1). Similarly, 66% of experiments in lateral ALPM
generated myocardial progeny (Fig. 3B, Table 1). In contrast, only 9% of experiments in rostral
ALPM generated myocardial progeny (Fig. 3B, Table 1). Instead, we found labeled endocardial
progeny in 40% of rostral ALPM experiments (Fig. 3B, Table 1). In rostral ALPM experiments
that generated myocardial progeny, labeled cells were located near the boundary between scl
and hand2 expression and not in the most rostral region tested (Fig. 3A,B, Table 1), suggesting
that the myocardial progenitors labeled alongside the scl/hand2 border might have originated
in hand2-expressing ALPM. Thus, our data indicate that the zebrafish HFR extends across
medial and lateral ALPM, with little or no contribution from rostral ALPM.
Although myocardial progenitors arise in both medial and lateral ALPM, our fate map indicates
a striking difference between the chamber identities of the cardiomyocytes derived from these
two territories. Of the medial ALPM experiments that produced myocardial progeny, 96% of
embryos exhibited labeled cardiomyocytes in the ventricle, whereas only 38% of embryos
exhibited labeled cardiomyocytes in the atrium (Fig. 3C, Table 1). The converse was observed
in lateral ALPM experiments that produced myocardial progeny: only 19% of embryos
contained labeled ventricular cardiomyocytes, whereas 98% of embryos contained labeled
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atrial cardiomyocytes (Fig. 3C, Table 1). These data demonstrate a general medial-lateral
organization of ventricular and atrial myocardial progenitors within the HFR, consistent with
the previously documented spatial organization of ventricular and atrial progenitors in the late
blastula (Keegan et al., 2004) and medial-lateral pattern of ventricular myosin heavy chain and
atrial myosin heavy chain expression as myocardial differentiation proceeds in the ALPM
(Yelon et al., 1999;Berdougo et al., 2003).
Combining our fate map and gene expression data, we conclude that the rostral and mediolateral
boundaries of the HFR correspond well with the boundaries of hand2 expression. Although
previous studies have suggested that nkx2.5 expression marks the zebrafish HFRs (Serbedzija
et al., 1998), the larger domain of hand2 expression more accurately reflects HFR dimensions
and includes atrial progenitors during the 6–9 somite stage. At later stages, however, nkx2.5 is
expressed in both ventricular and atrial myocardium (Yelon et al., 1999). Similarly, fate maps
of the chick HFR have indicated that myocardial progenitors, mostly of atrial identity, reside
beyond the boundary of Nkx2-5 expression in the early ALPM (Redkar et al., 2001; Hochgreb
et al., 2003).
Hand2 potentiates myocardial differentiation within the HFR
Given the correlation of hand2 expression with the dimensions of the HFR, we examined the
function of Hand2 within this region. Our previous analyses of zebrafish hands off/hand2
(han) mutants have suggested that Hand2 plays a permissive role in promoting cardiomyocyte
production, rather than an instructive role in assigning myocardial identity: han mutants contain
few cardiomyocytes, but ectopic expression of hand2 does not seem to create ectopic
cardiomyocytes (Yelon et al., 2000). Consistent with this proposed role, we find that loss of
Hand2 function does not affect the overall dimensions of the HFR. Initial patterns of gene
expression within the ALPM appear normal in han mutants (compare Fig. 4A–F to Fig.1D–
I). Notably, nkx2.5 expression is not diminished (Fig. 4A–C and Yelon et al., 2000), and scl
expression does not expand caudally (Fig. 4D–F). Additionally, fate mapping shows that
myocardial progenitors reside throughout the medial and lateral ALPM territories in han
mutants (Fig. 4I). However, the han mutant HFR is significantly less effective than the wild-
type HFR at producing cardiomyocytes: only 39% of fate mapping experiments in the han
mutant HFR generated labeled cardiomyocytes, compared to 69% of experiments in the wild-
type HFR (Figs. 3B, 4I, Table 1; p<0.05, Student’s t-test). Instead, labeled cells from the
han mutant HFR were often found adjacent to differentiated cardiomyocytes (black arrowheads
in Fig. 4G,H); we detected these cells in 76% of han mutant experiments, and did not find
similar cells in wild-type embryos. Although these flanking cells do not express terminal
myocardial differentiation markers such as cmlc2, they are found in a region where many cells
express nkx2.5 (Fig. 4M–O), suggesting that they could represent cardiac progenitors that
initiate, but fail to complete, myocardial differentiation. Thus, although not required to set HFR
boundaries, Hand2 plays an important role in the potentiation of myocardial differentiation
within the HFR.
Ectopic cardiomyocytes arise from rostral ALPM in cloche mutants
Even though Hand2 does not appear to be responsible for cardiac specification, hand2
expression does seem to be a useful marker of the location of the HFR. We hypothesized that
genes critical for delimiting cardiac developmental potential would also regulate the extent of
hand2 expression. We therefore proceeded to analyze the expression of hand2 in a collection
of zebrafish mutants with cardiac defects (Alexander et al., 1998), and we discovered that
mutation of the cloche (clo) locus has a striking effect on the regulation of hand2. Specifically,
we found that hand2 expression in clo mutants extends beyond its normal boundary, exhibiting
strong expression throughout the rostral ALPM (Fig. 5A,B). This ectopic expression does not
represent a distortion of ALPM morphology, since ALPM shape and size appear normal in
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clo mutants (Fig. 5C,D). The molecular identity of the clo gene has yet to be reported, but
previous studies have demonstrated that clo is required for specification of endothelial and
hematopoietic lineages (Stainier et al., 1995; Liao et al., 1997; Liao et al., 1998; Liao et al.,
2000; Parker and Stainier, 1999; Lieschke et al., 2002; Sumanas et al., 2005; Thompson et al.,
1998). Interestingly, progenitors for several of the cell types absent in clo mutants – endocardial
cells, head vessels, and myeloid cells – originate within the rostral ALPM (Fig. 3B, Table 1)
(Herbomel et al., 1999; Lieschke et al., 2002; Hsu et al., 2004).
The rostral extension of hand2 expression in clo mutants suggested that these embryos might
contain expanded HFRs. Consistent with this idea, we found that clo mutants produce extra
cmlc2-expressing cells, many of which extend rostrally beyond the primary bilateral
populations of cardiomyocytes (Fig. 5E,F). These extra cells require Hand2 for their efficient
differentiation, just like wild-type cardiomyocytes (Supplemental Fig. 1): han;clo double
mutants exhibit expanded nkx2.5 expression, like clo mutants, but only exhibit a small number
of differentiated cardiomyocytes, like han mutants. Extra cardiomyocytes are also evident
within the clo mutant heart at later stages. By 48 hpf, the clo mutant heart is markedly
dysmorphic, with a misshapen, compact ventricle and a dilated atrium (Fig. 5G,H), phenotypes
that had been attributed to the loss of endocardium (Stainier et al., 1995). Comparison of the
number of cardiomyocytes expressing the transgene Tg(cmlc2:DsRed2-nuc) (Mably et al.,
2003) demonstrated a trend toward a surplus of cardiomyocytes in clo mutant hearts (Fig. 5I-
K). In particular, clo mutants exhibit a statistically significant increase in the number of atrial
cardiomyocytes, compared to wild-type embryos (Fig. 5K). The number of ventricular
cardiomyocytes appears relatively unaffected (Fig. 5K).
The ectopic hand2 expression and myocardial surplus, together with the previously
demonstrated vessel and blood deficiencies (Stainier et al., 1995; Liao et al., 1997; Liao et al.,
1998; Liao et al., 2000; Parker and Stainier, 1999; Lieschke et al., 2002; Sumanas et al.,
2005; Thompson et al., 1998), led us to suspect that the excess cardiomyocytes in clo mutants
could arise from a fate transformation of rostral ALPM. To test this, we examined the clo
mutant rostral ALPM fate map. As shown above, wild-type rostral ALPM rarely contains
myocardial progenitors (9% of rostral ALPM experiments; Fig. 3B, Table 1). In strong contrast,
75% of experiments in clo mutant rostral ALPM generated labeled myocardial progeny (Fig.
5M, Table 1). In these embryos, labeled cardiomyocytes were frequently found in both
chambers (Table 1), indicating that the clo mutant rostral ALPM contains both ventricular and
atrial myocardial progenitors. However, labeled atrial cardiomyocytes typically outnumbered
labeled ventricular cardiomyocytes (Fig. 5L). This may reflect an important role of
endocardial-myocardial signaling during ventricular chamber maturation and growth, after the
heart tube is assembled; this function of the endocardium has been suggested by previous
studies in mouse (e.g. Lavine et al., 2005; Grego-Bessa et al., 2007). Overall, our fate map data
clearly demonstrate a fate transformation within the rostral ALPM of clo mutants: rather than
producing progenitors of endothelial and hematopoietic lineages, this territory produces
ectopic myocardial progenitors. Therefore, clo acts as a repressor of cardiac specification in
the rostral ALPM.
Latent cardiac potential revealed by inhibition of vasculogenesis and hematopoiesis
Prior studies of clo mutants have suggested that clo functions atop a hierarchy of genes
controlling vessel and blood development (Stainier et al., 1995; Liao et al., 1997; Liao et al.,
1998; Thompson et al., 1998). We therefore wondered whether downstream components of
these genetic pathways could, like clo, act to repress rostral expression of hand2 and cmlc2.
We chose to investigate whether the genes scl and etsrp could play this role. Both scl and
etsrp encode transcription factors and are expressed in the rostral ALPM (Fig. 1G-J) (Gering
et al., 1998; Liao et al., 1998; Sumanas and Lin, 2006; Pham et al., 2006). Loss-of-function
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studies have shown that Scl and Etsrp are essential components of rostral vasculogenic and
myelopoietic specification programs (Patterson et al., 2005; Dooley et al., 2005; Juarez et al.,
2005; Sumanas and Lin, 2006). Additionally, overexpression of these genes can induce ectopic
expression of vessel and blood markers (Gering et al., 1998; Dooley, et al., 2005; Pham et al.,
2006; Sumanas and Lin, 2006); furthermore, overexpression of scl together with lmo2 induces
broad, ectopic vessel and blood specification at the expense of other mesodermal cell types,
including myocardium (Gering et al., 2003). Both scl and etsrp act downstream of clo: their
expression is dramatically reduced in clo mutants, and overexpression of either gene can rescue
aspects of the clo vascular or hematopoietic phenotype (Liao et al., 1998; Dooley et al.,
2005; Sumanas et al., 2005; Sumanas and Lin, 2006).
To determine whether scl and etsrp are required to repress cardiogenesis, we used previously
characterized anti-scl and anti-etsrp morpholinos (MOs) to knock down gene function (Juarez
et al., 2005; Sumanas and Lin, 2006). Embryos injected with anti-scl or anti-etsrp MOs
displayed weak expression of hand2 in the rostral ALPM (Fig. 6A–C). Injection of both anti-
scl and anti-etsrp MOs (hereafter referred to as anti-scl+etsrp MOs) elicited strong rostral
expression of hand2 (Fig. 6D), similar to that observed in clo mutants (Fig. 5B). Additionally,
injection of anti-scl+etsrp MOs resulted in rostral extension of cmlc2 expression (Fig. 6E,F),
formation of a misshapen heart with an enlarged atrium (Fig. 6G,H), and production of too
many cardiomyocytes (Fig. 6I), all of which are reminiscent of the clo mutant phenotype (Fig.
5E–H,K). Conversely, overexpression of scl and etsrp induces ectopic expression of rostral
ALPM markers, like fli1a, in the HFR (Fig. 7A–C), reduces hand2 expression (Fig. 7D–F),
and decreases cardiomyocyte production (Fig. 7G–I). Together, these data show that scl and
etsrp, both of which function downstream of clo to promote vasculogenesis and hematopoiesis,
are also essential to override the latent cardiac developmental potential residing within rostral
ALPM and thereby limit heart size.
DISCUSSION
Taken together, our data reveal a previously unrecognized mechanism for limiting heart size:
components of the vessel and blood specification pathways repress formation of cardiac
progenitors and thereby restrict the dimensions of the heart-forming region. In the early
zebrafish embryo, the entire ALPM possesses cardiac developmental potential. However, not
all of this potential is fulfilled. Only the hand2-expressing portion of the ALPM produces
myocardium, whereas the rostral territory gives rise to endothelium and myeloid cells. We find
that this subdivision of the ALPM is mediated by clo and its downstream effectors scl and
etsrp. In addition to promoting vessel and blood specification, these genes also inhibit cardiac
specification within rostral ALPM. Thus, the induction of vessel and blood lineages creates a
rostral boundary for cardiogenesis within a larger heart field.
Our findings indicate a close relationship between myocardial, endothelial, and hematopoietic
lineages during their development. Consistent with this, several studies in mouse have indicated
a common origin for multiple cardiovascular lineages. Lineage analysis in vivo and analysis
of progenitor differentiation in vitro have suggested that myocardial, endothelial, and
hematopoietic lineages share a common progenitor expressing Flk1 (Ema et al., 2006; Motoike
et al., 2003), and recent experiments employing ES cell differentiation in vitro have shown that
Flk1-expressing progenitors give rise to myocardium, endothelium and vascular smooth
muscle (Kattman et al., 2006). Other complementary experiments indicate that myocardium,
endothelium, and vascular smooth muscle can all arise from progenitors expressing Isl1,
Nkx2-5, and Flk1 (Moretti et al., 2006). Despite the wealth of evidence supporting the existence
of multipotent cardiovascular progenitors, it is not yet understood how individual progenitors
become committed to distinct cardiovascular fates. Our work sheds light on the regulation of
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these lineage decisions: induction of genes like scl and etsrp is a critical mechanism, not only
for promoting vasculogenesis and hematopoiesis, but also for repressing cardiogenesis.
The precise molecular interface between the vessel, blood, and cardiac specification pathways
will be an important focus for future studies. It is possible that Scl and/or Etsrp could be directly
involved in repressing expression of myocardial genes. Scl can act either as a repressor or an
activator depending on the context of its protein-protein interactions (Lecuyer and Hoang,
2004), and in vitro assays have suggested that Scl is capable of repressing muscle differentiation
by disrupting the activities of other bHLH transcription factors (Hofmann and Cole, 1996).
However, the relationship between specification pathways could also be less direct and more
complex, with genes downstream of Scl and Etsrp repressing genes upstream of those required
for myocardial specification. Elucidation of the partners and targets of Scl and Etsrp will help
to illuminate the transcriptional networks that link cardiovascular specification pathways.
In addition to revealing an important interaction between cardiovascular pathways, our studies
highlight the developmental plasticity inherent to the rostral portion of the zebrafish ALPM.
The rostral ALPM has previously been implicated in facilitating repair of the zebrafish HFR
following its partial ablation (Serbedzija et al., 1998). The multipotency of the zebrafish rostral
ALPM also suggests an appealing mechanism for facilitating the alteration of heart size and
structure during the course of vertebrate evolution. The amniote heart is significantly larger
and more complex than the teleost heart, but it is not yet clear what regulatory changes made
these structural modifications possible (Olson, 2006). A recent study in Ciona has indicated
that the addition of more cells to the myocardial progenitor pool can provide opportunities for
structural innovation, such as the addition of a cardiac chamber (Davidson et al., 2006). Our
findings suggest that a reservoir of latent cardiac potential, akin to that found in the zebrafish
rostral ALPM, could have provided the raw material necessary to elaborate upon the evolving
heart. Even slight changes in the regulation of anterior vasculogenesis and hematopoiesis could
have exposed a new source of myocardial progenitors in an ancestral vertebrate. This surplus
could have led to augmentation of the HFR, allowing development of a larger organ, as seen
in our experiments. Furthermore, we speculate that changes in utilization of a latent reservoir
of cardiac potential could have provided the origin of the amniote second heart field, allowing
enhanced structural complexity through the addition of new cardiac chambers.
In conclusion, our data reveal an important regulatory relationship between cardiovascular
specification pathways. The repression of myocardial specification by vascular and
hematopoietic pathways coordinates development of the cardiovascular system, both by
regulating the divergence of lineages from a common progenitor and by restricting heart size.
Importantly, our insight into the interplay between cardiovascular pathways could have a
significant impact on strategies for regenerative medicine. Specifically, our studies suggest
that interference with Scl and Etsrp function could be an effective means of directing
multipotent cardiovascular progenitor cells toward myocardial differentiation. Thus, this work
will likely motivate new approaches for harnessing the developmental potential of
cardiovascular progenitor cells to facilitate cellular therapies for damaged cardiac muscle.
EXPERIMENTAL PROCEDURES
Mutations, morpholinos and RNA injections
To generate mutant embryos, we intercrossed heterozygotes for the mutations hans6 (Yelon et
al., 2000), clos5 (Field et al., 2003), and closk4. The closk4 allele was isolated as a spontaneous
mutation in our zebrafish facility; closk4 mutants appear phenotypically identical to clos5
mutants.
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All MOs used in our studies were previously characterized and shown to be reasonably effective
and specific (Juarez et al., 2005; Sumanas and Lin, 2006). All MOs behaved as previously
reported, as assessed by the loss of vessels and blood. To knock down scl, we injected 12.5 ng
of a 2:3 mix of E2I2 and E3I3 anti-scl MOs (Juarez et al., 2005). To knock down etsrp, we
injected 12 ng of a 1:1 mix of anti-etsrp MO1 and MO2 (Sumanas and Lin, 2006). For anti-
scl+etsrp MOs, we injected 12 ng of a 1:1 combination of the mixes described above.
Previously described plasmids were used to synthesize scl and etsrp RNA (Dooley et al.,
2005; Pham et al., 2006). Embryos were injected with a combination of 40–50 ng of scl RNA
and 4–8 ng of etsrp RNA; injection of these amounts results in variable and mosaic phenotypes
but avoids toxicity and severe malformations.
All care and use of zebrafish and embryos complied with local animal welfare laws, guidelines,
and policies, as described in animal protocol #060911-01, approved by the New York
University School of Medicine Institutional Animal Care and Use Committee.
In situ hybridization
Single-color wholemount in situ hybridization was performed as previously described (Yelon
et al., 1999). Two-color fluorescent hybridization was conducted according to a Yelon lab
protocol that is optimized for difficult riboprobes and is available upon request. Briefly, we
used pairs of riboprobes, one labeled with digoxigenin (DIG) and the other labeled with
dinitrophenol (DNP). DNP probes were synthesized as previously described (Long and
Rebagliati, 2002) using a DNP Label-It kit (Mirus). DNP incorporation was enhanced by
extending the labeling incubation to 2.5 hours and by using 1.5 μL of labeling reagent per μg
of RNA. Following probe hybridization, washes, and blocking, embryos were incubated
overnight at 4°C with anti-DNP Fab fragments conjugated to horseradish peroxidase (HRP)
(PerkinElmer, 1:400 dilution). Embryos were then incubated with DNP tyramide
(PerkinElmer, 1:25 dilution, 30 minutes at room temperature) to amplify DNP deposition. Next,
stringent conditions were used to insure removal of all HRP activity. Embryos were washed
in PBT (PBS, 0.1% Tween-20) containing 3% peroxide (4 times, 15 minutes per wash) and
then in 0.1 M glycine, pH 2.2 with 0.1% Tween-20 (4 times, 15 minutes per wash). Finally,
embryos were washed in PBT, blocked, and incubated overnight at 4°C with anti-DIG HRP-
conjugated Fab fragments (Roche, 1:400 dilution). Embryos were then incubated with
fluorescein (FLU) tyramide (PerkinElmer), followed by removal of HRP activity, as above.
Next, we conducted a second round of tyramide deposition. Embryos were first incubated with
anti-DNP HRP-conjugated Fab fragments, followed by incubation with Cy3 tyramide
(PerkinElmer, 1:25 dilution, 30 minutes at room temperature). After removal of HRP activity,
embryos were incubated with anti-FLU HRP-conjugated Fab fragments, followed by
incubation with FLU tyramide. After a final set of PBT washes, embryos were stored in
SlowFade Antifade solution (Invitrogen).
Photoactivation of fluorescein in the ALPM
Caged fluorescein dextran was prepared and injected as previously described (Keegan et al.,
2004), with the exception of being injected directly into the single cell of newly fertilized
embryos. When injected embryos reached the 6–9 somite stage, they were mounted dorsal side
up in a well gouged from 2% agarose and filled with embryo water. Caged fluorescein was
photoactivated in clusters of 10–15 ALPM cells by exposure to 1 second pulses from a 375
nm pulsed nitrogen laser (Micropoint Laser System, Photonic Instruments). Laser light was
focused through a 40x water immersion objective on a Zeiss Axioplan 2 microscope equipped
with a cooled CCD camera (Pentamax) and automated shutters (Uniblitz). For lateral ALPM
labeling, we avoided labeling cells located more than 4 cell widths from the lateral edge of the
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ALPM. To label medial ALPM, we labeled cells that were at least 4 cell widths interior to the
lateral edge of the ALPM.
Fluorescein detection and scoring of labeled cells
Labeled embryos were fixed at the desired stage: either immediately (Fig. 2E,F,H,I), at 30 hpf
(Fig.4G,H), or at 44 hpf (Figs. 2J–L, 5L). clo mutants were fixed at 44 hpf, our lab’s standard
stage for scoring labeled cells (Keegan et al., 2004). However, han mutants were fixed at 30
hpf, since the han mutant myocardium remains under the hindbrain at 44 hpf and is therefore
obscured by pigmentation. Wild-type data represent a combination of embryos fixed at 30 and
44 hpf.
Following fixation, embryos were processed by in situ hybridization to create a counterstain
for fluorescein detection. For embryos fixed at 30 and 44 hpf, cmlc2 expression was visualized
as previously described (Keegan et al., 2004) using the substrate 5-Bromo-6-Chloro-3-Indolyl
Phosphate (‘magenta phos’; Sigma B-5667). Cells labeled with uncaged fluorescein were then
detected by immunohistochemistry and scored for tissue contributions based on location,
morphology, and counterstaining, as previously described (Keegan et al., 2004). In particular,
we used morphological criteria to distinguish myocardial cells, which are relatively round and
tend to be oriented circumferentially around the heart, from endocardial cells, which are
relatively elongated and tend to project longitudinally. Additionally, we assessed localization
of labeled cells relative to the myocardial counterstain. The number of labeled progeny detected
varied between individual embryos. Contributions to pharyngeal pouches ranged between 5
and 50 cells and contributions to myocardium or endocardium ranged between 1 and 30 cells.
For embryos fixed immediately after labeling, we used our two-color fluorescent in situ
hybridization technique to counterstain for ALPM markers (scl or nkx2.5) and to detect uncaged
fluorescein. Briefly, DIG riboprobe was detected with anti-DIG HRP-conjugated Fab
fragments, incubation with DNP tyramide, and a second round of tyramide depostion with anti-
DNP HRP-conjugated Fab fragments and Cy3 tyramide. Then, uncaged fluorescein was
detected with anti-FLU HRP-conjugated Fab fragments and a FLU tyramide reaction, with an
optional second round of tyramide deposition.
Cardiomyocyte counting
To count cardiomyocytes, we employed the transgene Tg(cmlc2:DsRed2-nuc) (Mably et al.,
2003), as described in a separate manuscript (J.S. Waxman, B.R.K., and D.Y., manuscript
submitted). Briefly, we processed transgenic embryos using a standard immunofluorescence
protocol (Alexander et al., 1998), the primary antibodies S46 (anti-Amhc; 1:20) and anti-
DsRed (1:4000; Clontech), and the secondary antibodies goat anti-mouse IgG1 FITC (1:100,
Southern Biotechnology Associates, Inc.) and donkey anti-rabbit Alexa 594 (1:1000,
Invitrogen). We then counted the red fluorescent nuclei in each cardiac chamber.
Imaging
Fluorescent in situ hybridization images were captured with a Zeiss LSM 510 confocal
microscope and processed with Zeiss LSM 510 and Adobe Photoshop 7 software. Capture of
DIC and FITC images of live embryos was controlled by Metamorph Imaging System software
(v6.1r3, Universal Imaging). All other embryos were photographed with Zeiss M2Bio and
Axioplan microscopes outfitted with Zeiss Axiocam digital cameras; images were processed
with Zeiss AxioVision (v3.0.6) and Adobe Photoshop 7 software.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Gene expression patterns divide the ALPM into three territories. (A–K) Two-color fluorescent
in situ hybridization of wild-type embryos at the 7 somite stage, dorsal views, anterior to the
top. All images shown at the same magnification; scale bar represents 100 μm. (A) Overlay of
gata4 (B) and hand2 (C) expression. Expression of hand2 is observed throughout the caudal
portion of gata4-expressing ALPM, but is excluded from rostral ALPM. (D) Overlay of
gata4 (E) and nkx2.5 (F) expression. Expression of nkx2.5 is observed within a medial portion
of the caudal ALPM, but is excluded from lateral and rostral ALPM. (G) Overlay of gata4 (H)
and scl (I) expression. Expression of scl is observed in rostral ALPM. (J) Overlay of hand2
(green) and scl (red) expression. Expression patterns of scl and hand2 do not overlap. (K)
Schoenebeck et al. Page 13
Dev Cell. Author manuscript; available in PMC 2009 July 13.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Overlay of hand2 (green) and nkx2.5 (red) expression. Expression of hand2 extends beyond
the lateral limit of nkx2.5 expression. (L) Schematic of 7 somite stage ALPM, superimposed
onto a dorsal view of a live embryo; dashes outline the tip of the notochord. Comparison of
gene expression patterns defines rostral (white), medial (black), and lateral (grey) ALPM
territories. Although ALPM morphology varies slightly during the 6–9 somite stage and
between individual embryos, relative patterns of gene expression consistently demarcate these
territories.
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Figure 2.
Constructing a fate map of ALPM territories. (A–I) Dorsal views, anterior to the top, of wild-
type embryos at the 6–9 somite stage. Scale bars represent 100 μm. (A–C) Photoactivation of
caged fluorescein labels groups of cells in the ALPM. (A) DIC image of a live embryo. The
lateral edge of the ALPM (dashed line) is visible. (B) Fluorescence indicates photoactivation
of caged fluorescein. (C) Overlay of DIC and fluorescent images confirms location of labeled
cells. In this example, the ~14 labeled cells reside in the medial ALPM. (D,G) Schematics
indicate ALPM regions that were interrogated by fate mapping. (D) Two regions within the
rostral ALPM were examined, on both sides of the embryo: a region flanking the forebrain
(region 1) and a region flanking the midbrain-hindbrain boundary (region 2). (E,F) Examples
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of control experiments performed to assess accuracy of labeling rostral ALPM. Cells were
labeled in the regions depicted by green ovals in (D) and immediately processed to compare
scl expression (red) relative to uncaged fluorescein (green). (E) Cells labeled in region 2 were
located solely within the scl expression domain in 5/9 experiments; in the other 4 experiments,
labeling crossed the posterior border of scl expression and therefore overlapped with hand2-
expressing territory. (F) Cells labeled in region 1 were located within the scl expression domain
in 8/8 experiments. (G) 8 regions within the caudal ALPM were examined, on both sides of
the embryo: 4 medial regions and 4 lateral regions distinguished by their position along the
anterior-posterior axis. (H,I) Examples of control experiments performed to assess
mediolateral labeling accuracy. Cells were labeled in the regions depicted by green ovals in
(D) and immediately processed to compare nkx2.5 expression (red) relative to uncaged
fluorescein (green). (H) Cells labeled in lateral regions did not express nkx2.5 (n=8/9). (I)
Conversely, cells labeled in medial regions did express nkx2.5 (n=6/6). (J–L) Scoring progeny
of labeled ALPM cells at 44 hpf. In situ hybridization indicates expression of cmlc2 (magenta)
in cardiomyocytes, and immunohistochemistry for uncaged fluorescein (blue) indicates
progeny of labeled cells. (J) Frontal view, dorsal to the top; in this example, labeled cells
became ~30 atrial cardiomyocytes (black arrowheads). (K, L) Lateral views, anterior to the
right. (K) In this example, 30–40 labeled cells populated a pharyngeal pouch (white arrow).
(L) In this example, 3–4 labeled cells (black arrow) contributed to the ventricular endocardium.
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Figure 3.
Fate map of cardiac progenitors within ALPM territories. (A–C) Schematics depicting the
progenitor composition of medial, lateral, and rostral ALPM territories. Dorsal views of the
right side of the ALPM, anterior to the top. (A) Schematic of gene expression patterns that
distinguish medial (black), lateral (grey), and rostral (white) ALPM territories, as in Fig. 1L.
(B) Myocardial progenitors arise from medial and lateral territories and are only rarely detected
in rostral territory. In contrast, endocardial progenitors arise from rostral territory. For each
region tested, pie charts depict the proportions of experimental embryos exhibiting a particular
type of labeled progeny. Colored pie pieces represent embryos that produced labeled
myocardial progeny (blue), labeled endocardial progeny (pink), both myocardial and
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endocardial labeled progeny (maroon), and only non-cardiac labeled progeny (green). Data
shown are a merger of experiments from the left and right sides of the embryo; our data did
not reveal any left-right asymmetry of the fate map. (C) Ventricular and atrial myocardial
progenitors appear spatially organized within caudal ALPM, with ventricular progenitors
tending to originate medially and atrial progenitors tending to originate laterally. Pie charts
depict the chamber contributions of labeled cells in the subset of experimental embryos
containing labeled myocardial progeny. Colored pie pieces represent embryos that produced
labeled ventricular cardiomyocytes (red), labeled atrial cardiomyocytes (yellow), and both
ventricular and atrial cardiomyocytes (brown). See Table 1 for data reflected in schematics.
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Figure 4.
Hand2 potentiates myocardial differentiation. (A–F) ALPM territories appear to be established
normally in han mutant embryos. Two-color fluorescent in situ hybridization of han mutants
at the 7 somite stage, dorsal views, anterior to the top. Scale bars represent 100 μm. (A) Overlay
of gata4 (B) and nkx2.5 (C) expression. (D) Overlay of gata4 (E) and scl (F) expression.
Expression patterns of gata4, nkx2.5, and scl divide the han mutant ALPM into normally
proportioned rostral, medial, and lateral regions. (G–I) Fate map of the caudal ALPM in han
mutants indicates that Hand2 is required to facilitate effective differentiation of myocardial
progenitors from medial and lateral ALPM territories. (G,H) Dorsal views of han mutant
embryos at 30 hpf, anterior to the top. In situ hybridization indicates expression of cmlc2
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(magenta) in cardiomyocytes, and immunohistochemistry for uncaged fluorescein (blue)
indicates progeny of labeled cells. In han mutants, labeled cells from caudal ALPM can give
rise to cardiomyocytes (white arrowhead, H) but also frequently become seemingly
undifferentiated cells (black arrowheads, G and H) flanking the cardiomyocytes. Labeled cells
also contribute to pharyngeal pouches (arrows, G and H). (I) Fate map of han mutant caudal
ALPM. For each region tested, pie charts depict the proportions of experimental embryos
producing labeled myocardial progeny (blue) and only non-cardiac labeled progeny (green).
Myocardial progenitors were found in all regions examined, but the frequency with which
labeled han mutant ALPM produced cardiomyocytes was reduced, relative to wild-type,
throughout both medial and lateral territories (compare to Fig. 3B). See Table 1 for data
reflected in schematic. (J–O) han mutants exhibit ineffective myocardial differentiation. Two-
color fluorescent in situ hybridization at 24 hpf, dorsal views, anterior to the top. (J,M) Overlays
of cmlc2 (K,N) and nkx2.5 (L,O) expression. In wild-type embryos (J–L), cmlc2 and nkx2.5
are both expressed throughout the heart tube. Additional expression of nkx2.5 marks the
forming pharyngeal pouches (asterisks). (M–O) In han mutants, a reduced number of
cardiomyocytes span the midline. Undifferentiated, nkx2.5-expressing ALPM cells (arrows)
flank the cardiomyocytes.
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Figure 5.
clo mutants generate ectopic cardiomyocytes. (A–H) In situ hybridization depicts expression
of hand2 (A,B), gata4 (C,D) and cmlc2 (E–H) in wild-type (A,C,E,G) and clo mutant (B,D,F,H)
embryos. (A–F) Dorsal views, anterior to the top, at the 7 somite (A–D) and 19 somite (E,F)
stages. Scale bars represent 100 μm. (A,B) hand2 is ectopically expressed in the rostral ALPM
of clo mutant embryos (arrows, B). (C,D) Expression of gata4 is indistinguishable between
wild-type and clo mutant embryos, indicating normal rostral ALPM morphology. (E,F) clo
mutants exhibit a rostral extension of cmlc2 expression (arrows). (G,H) Frontal views, dorsal
to the top. At 48 hpf, the wild-type heart is looped, with morphologically distinct chambers,
whereas the clo mutant heart appears unlooped, with a small, compact ventricle and a large,
dilated atrium. (I–K) clo mutant hearts contain too many cardiomyocytes. (I,J) Frontal views
of hearts at 52 hpf. Immunofluorescence indicates that both chambers express the
transgeneTg(cmlc2:DsRed2-nuc) (red) (Mably et al., 2003). Atria are labeled with the anti-
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Amhc antibody S46 (aqua) (Berdougo et al., 2003). (K) Counting of cardiomyocyte nuclei
reveals a statistically significant increase (asterisk) in the number of atrial cardiomyocytes in
clo mutants (p<0.002, Student’s t-test; n=11 of each genotype). Bar graph indicates mean and
standard error of each data set. (L,M) Fate map of the rostral ALPM in clo mutants indicates
formation of ectopic myocardial progenitors. (L) Frontal view of clo mutant embryo at 44 hpf,
dorsal to the top. In situ hybridization indicates expression of cmlc2 (magenta) in
cardiomyocytes, and immunohistochemistry for uncaged fluorescein (blue) indicates progeny
of labeled cells. In this example, labeled cardiomyocytes are found in the atrium (black
arrowheads) and in the ventricle (white arrowhead). (M) Fate map of clo mutant rostral ALPM.
For each region tested, pie charts depict the proportions of experimental embryos producing
labeled myocardial progeny (blue) and only non-cardiac labeled progeny (green). See Table 1
for data reflected in schematic. In clo mutants, both rostral ALPM regions frequently gave rise
to cardiomyocytes, indicating a significant fate transformation (compare to Fig. 3B). We have
not performed fate map experiments in the clo mutant medial or lateral ALPM, since clo
mutants do not seem to exhibit significant changes in gene expression patterns in these
territories (J.J.S., B.R.K., and D.Y., unpublished data).
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Figure 6.
Latent cardiac potential in rostral ALPM is revealed by inhibition of vasculogenesis and
myelopoiesis. (A–H) In situ hybridization depicts expression of hand2 (A–D) and cmlc2 (E–
H) in wild-type (A,E,G) and MO-injected (B–D,F,H) embryos. (A–F) Dorsal views, anterior
to the top, at the 7 somite (A–D) and 20 somite (E,F) stages. (G,H) Frontal views, dorsal to the
top, at 48 hpf. Scale bars represent 100 μm. (A–D) hand2 is ectopically expressed in the rostral
ALPM of embryos when scl and etsrp are knocked down. Injections of anti-scl (B) or anti-
etsrp (C) MOs caused weak expression of hand2 in rostral ALPM (arrows; anti-scl MOs,
n=6/10; anti-etsrp MOs, n=6/12). Rostral hand2 expression was not observed in control sibling
embryos (n=0/24). Injection of anti-scl+etsrp MOs (D) caused robust expression of hand2 in
rostral ALPM (arrows; strong expression, n=10/17; weak expression, n=7/17). Thus, injection
of anti-scl+etsrp MOs phenocopies a loss of clo function. (E,F) Injection of anti-scl+etsrp
MOs causes a rostral extension of cmlc2 expression (arrows; injected embryos, n=25/31;
control siblings, n=0/33). (G,H) Injection of anti-scl+etsrp MOs results in cardiac chamber
morphology resembling that of clo mutants (injected embryos, n=8/10; control siblings,
n=0/15). (I) Hearts of anti-scl+etsrp MO-injected embryos contain too many cardiomyocytes.
Counting of cardiomyocyte nuclei reveals statistically significant increases (asterisks) in the
total number of cardiomyocytes and the number of atrial cardiomyocytes in MO-injected
embryos (p<0.0002, Student’s t-test; n=13 uninjected controls and 15 injected embryos). Bar
graph indicates mean and standard error of each data set.
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Figure 7.
Overexpression of scl and etsrp promotes vasculogenesis and inhibits heart formation. In
situ hybridization depicts expression of fli1a (A–C), hand2 (D–F), and cmlc2 (G–I) in wild-
type (A,D,G) and scl+etsrp RNA-injected embryos displaying severe (B,E,H) and moderate
(C,F,I) phenotypes. Dorsal views, anterior to the top, at the 7 somite (A–F) and 30 hpf (G–I)
stages. Scale bars represent 100 μm. (A–C) Overexpression of scl and etsrp induces ectopic
expression of fli1a, including expression within the HFR (arrowheads; severe phenotype,
n=7/15; moderate phenotype, n=5/15). (D–F) RNA-injected embryos exhibit reduced
expression of hand2 (arrows; severe phenotype, n=14/34; moderate phenotype, n=15/34). (G–
I) RNA-injected embryos exhibit small, dysmorphic hearts (severe phenotype, n=9/11;
moderate phenotype, n=2/11).
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